NCT01745575View on ClinicalTrials.gov

Bioequivalence Trial of Alprazolam 2 mg Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

March 28, 2010

Primary Completion Date

April 5, 2010

Study Completion Date

April 5, 2010

Conditions

Anxiety Disorders

Interventions

DRUG

Alprazolam 2mg tablets

Reference product

DRUG

Alprazolam 2 mg tablets

Test product

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY